179 related articles for article (PubMed ID: 38235146)
21. Pre-existing effector T-cell levels and augmented myeloid cell composition denote response to CDK4/6 inhibitor palbociclib and pembrolizumab in hormone receptor-positive metastatic breast cancer.
Egelston C; Guo W; Yost S; Lee JS; Rose D; Avalos C; Ye J; Frankel P; Schmolze D; Waisman J; Lee P; Yuan Y
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33757987
[TBL] [Abstract][Full Text] [Related]
22. Immune profiling identifies CD8
Chen Z; Guo ML; Li YY; Yan K; Li L; Shen F; Guan H; Liu QZ; Xu B; Lian ZX
Front Immunol; 2022; 13():894919. PubMed ID: 36420264
[TBL] [Abstract][Full Text] [Related]
23. Frequency of Immune Cell Subtypes in Peripheral Blood Correlates With Outcome for Patients With Metastatic Breast Cancer Treated With High-Dose Chemotherapy.
Lafrenie RM; Speigl L; Buckner CA; Pawelec G; Conlon MS; Shipp C
Clin Breast Cancer; 2019 Dec; 19(6):433-442. PubMed ID: 31383605
[TBL] [Abstract][Full Text] [Related]
24. Aberrant Alteration of Circulating Lymphocyte Subsets in Small Cell Lung Cancer Patients Treated with Radiotherapy.
Li H; Yu H; Lan S; Zhao D; Liu Y; Cheng Y
Technol Cancer Res Treat; 2021; 20():15330338211039948. PubMed ID: 34851203
[No Abstract] [Full Text] [Related]
25. Clinicopathologic Features of Fatal Non-Anaplastic Follicular Cell-Derived Thyroid Carcinomas.
Xu B; Ibrahimpasic T; Wang L; Sabra MM; Migliacci JC; Tuttle RM; Ganly I; Ghossein R
Thyroid; 2016 Nov; 26(11):1588-1597. PubMed ID: 27480016
[TBL] [Abstract][Full Text] [Related]
26. HIV type 1 gp120-induced expansion of myeloid derived suppressor cells is dependent on interleukin 6 and suppresses immunity.
Garg A; Spector SA
J Infect Dis; 2014 Feb; 209(3):441-51. PubMed ID: 23999600
[TBL] [Abstract][Full Text] [Related]
27. CD8+ tumour-infiltrating lymphocytes and COX2 expression may predict relapse in differentiated thyroid cancer.
Cunha LL; Marcello MA; Nonogaki S; Morari EC; Soares FA; Vassallo J; Ward LS
Clin Endocrinol (Oxf); 2015 Aug; 83(2):246-53. PubMed ID: 25130519
[TBL] [Abstract][Full Text] [Related]
28. Immunological Subsets Characterization in Newly Diagnosed Relapsing-Remitting Multiple Sclerosis.
D'Amico E; Zanghì A; Parrinello NL; Romano A; Palumbo GA; Chisari CG; Toscano S; Raimondo FD; Zappia M; Patti F
Front Immunol; 2022; 13():819136. PubMed ID: 35273601
[TBL] [Abstract][Full Text] [Related]
29. Differential distribution and prognostic value of CD4
Shi ZY; Zhang SX; Li CH; Fan D; Xue Y; Cheng ZH; Wu LX; Lu KY; Wu ZF; Li XF; Liu HY; Li SJ
Front Immunol; 2022; 13():966550. PubMed ID: 36091039
[TBL] [Abstract][Full Text] [Related]
30. Stereotactic Ablative Radiation Therapy Induces Systemic Differences in Peripheral Blood Immunophenotype Dependent on Irradiated Site.
McGee HM; Daly ME; Azghadi S; Stewart SL; Oesterich L; Schlom J; Donahue R; Schoenfeld JD; Chen Q; Rao S; Fragoso RC; Valicenti RK; Canter RJ; Maverakis EM; Murphy WJ; Kelly K; Monjazeb AM
Int J Radiat Oncol Biol Phys; 2018 Aug; 101(5):1259-1270. PubMed ID: 29891204
[TBL] [Abstract][Full Text] [Related]
31. Myeloid-derived suppressor cells expansion is closely associated with disease severity and progression in HBV-related acute-on-chronic liver failure.
Zeng Y; Li Y; Xu Z; Gan W; Lu L; Huang X; Lin C
J Med Virol; 2019 Aug; 91(8):1510-1518. PubMed ID: 30905084
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.
Furlan JC; Bedard YC; Rosen IB
J Am Coll Surg; 2004 Mar; 198(3):341-8. PubMed ID: 14992733
[TBL] [Abstract][Full Text] [Related]
33. Pediatric Differentiated Thyroid Carcinoma of Follicular Cell Origin: Prognostic Significance of Histologic Subtypes.
Balachandar S; La Quaglia M; Tuttle RM; Heller G; Ghossein RA; Sklar CA
Thyroid; 2016 Feb; 26(2):219-26. PubMed ID: 26854950
[TBL] [Abstract][Full Text] [Related]
34. Vasoactive intestinal peptide induces CD14+HLA-DR‑/low myeloid-derived suppressor cells in gastric cancer.
Li G; Wu K; Tao K; Lu X; Ma J; Mao Z; Li H; Shi L; Li J; Niu Y; Xiang F; Wang G
Mol Med Rep; 2015 Jul; 12(1):760-8. PubMed ID: 25695487
[TBL] [Abstract][Full Text] [Related]
35. CD4+ T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients.
Dubinski D; Wölfer J; Hasselblatt M; Schneider-Hohendorf T; Bogdahn U; Stummer W; Wiendl H; Grauer OM
Neuro Oncol; 2016 Jun; 18(6):807-18. PubMed ID: 26578623
[TBL] [Abstract][Full Text] [Related]
36. Understanding of the immunological heterogeneity of canine mammary carcinomas to provide immunophenotypic features of circulating leukocytes as clinically relevant prognostic biomarkers.
Estrela-Lima A; Araújo MS; da Costa-Neto JM; Ribeiro LG; Damasceno KA; D'Assis MJ; Martins-Filho OA; Teixeira-Carvalho A; Serakides R; Cassali GD
Breast Cancer Res Treat; 2012 Feb; 131(3):751-63. PubMed ID: 21448671
[TBL] [Abstract][Full Text] [Related]
37. High Grade Differentiated Follicular Cell-Derived Thyroid Carcinoma Versus Poorly Differentiated Thyroid Carcinoma: A Clinicopathologic Analysis of 41 Cases.
Thompson LDR
Endocr Pathol; 2023 Jun; 34(2):234-246. PubMed ID: 37195480
[TBL] [Abstract][Full Text] [Related]
38. Using the American Thyroid Association Risk-Stratification System to Refine and Individualize the American Joint Committee on Cancer Eighth Edition Disease-Specific Survival Estimates in Differentiated Thyroid Cancer.
Ghaznavi SA; Ganly I; Shaha AR; English C; Wills J; Tuttle RM
Thyroid; 2018 Oct; 28(10):1293-1300. PubMed ID: 29897011
[TBL] [Abstract][Full Text] [Related]
39. Patterns of care for patients with primary differentiated carcinoma of the thyroid gland treated in Germany during 1996. U.S. and German Thyroid Cancer Group.
Hölzer S; Reiners C; Mann K; Bamberg M; Rothmund M; Dudeck J; Stewart AK; Hundahl SA
Cancer; 2000 Jul; 89(1):192-201. PubMed ID: 10897018
[TBL] [Abstract][Full Text] [Related]
40. The effects of tumor resection and adjuvant therapy on the peripheral blood immune cell profile in patients with colon carcinoma.
Krijgsman D; De Vries NL; Andersen MN; Skovbo A; Tollenaar RAEM; Bastiaannet E; Kuppen PJK; Hokland M
Cancer Immunol Immunother; 2020 Oct; 69(10):2009-2020. PubMed ID: 32399587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]